Literature DB >> 2547837

Endothelin binding to cultured calf adrenal zona glomerulosa cells and stimulation of aldosterone secretion.

E N Cozza1, C E Gomez-Sanchez, M F Foecking, S Chiou.   

Abstract

Endothelins are a group of potent vasoconstrictors whose structure was deduced from genomic DNA. ET-1 was first isolated from culture supernatants from porcine endothelial cells and ET-3 was identified from a rat DNA library. We report on the binding of 125I-ET-1 to zona glomerulosa cells in culture and on its ability to stimulate aldosterone secretion. Cultured calf adrenal zona glomerulosa cells have saturable, high affinity [Kd = 1.00 +/- 0.17 X 10(-10) M (SEM)] receptors which bind ET-1 in a temperature and time dependent manner. Binding was specific and angiotensin II, vasopressin, ANP, BNP, apamin, calcium channel agonists or antagonists did not interact with the receptor. ET-3 displaced 125I-ET-1 from the receptor with a relative potency of 0.39 +/- 0.1% (SEM) that of ET-1. ET-1 incubated with cultured glomerulosa cells stimulated aldosterone secretion in a dose dependent manner but it was less potent than angiotensin II. ET-3 had less than 1% the relative potency of ET-1 stimulating aldosterone secretion. This data suggest that ET-1 is an independent stimulator of aldosterone secretion and we are speculating that it might be important in those situations, like in malignant hypertension, where endothelial damage might result in increased ET-1 production.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547837      PMCID: PMC329753          DOI: 10.1172/JCI114226

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  Integrated cardiac, renal, and endocrine actions of endothelin.

Authors:  W L Miller; M M Redfield; J C Burnett
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

2.  Does endothelin mobilize calcium from intracellular store sites in rat aortic vascular smooth muscle cells in primary culture?

Authors:  N Miasiro; H Yamamoto; H Kanaide; M Nakamura
Journal:  Biochem Biophys Res Commun       Date:  1988-10-14       Impact factor: 3.575

3.  Cardiovascular, renal, and endocrine responses to intravenous endothelin in conscious dogs.

Authors:  K L Goetz; B C Wang; J B Madwed; J L Zhu; R J Leadley
Journal:  Am J Physiol       Date:  1988-12

4.  Molecular mechanism of action of the vasoconstrictor peptide endothelin.

Authors:  C Van Renterghem; P Vigne; J Barhanin; A Schmid-Alliana; C Frelin; M Lazdunski
Journal:  Biochem Biophys Res Commun       Date:  1988-12-30       Impact factor: 3.575

5.  Malignant hypertension: effect of therapy on renin and aldosterone.

Authors:  R G McAllister; C W Van Way; K Dayani; W J Anderson; E Temple; A M Michelakis; W S Coppage; J A Oates
Journal:  Circ Res       Date:  1971-05       Impact factor: 17.367

6.  Endothelin action on vascular smooth muscle involves inositol trisphosphate and calcium mobilization.

Authors:  P A Marsden; N R Danthuluri; B M Brenner; B J Ballermann; T A Brock
Journal:  Biochem Biophys Res Commun       Date:  1989-01-16       Impact factor: 3.575

7.  The failure of endothelin to displace bound, radioactively-labelled, calcium antagonists (PN 200/110, D888 and diltiazem).

Authors:  X H Gu; J J Liu; J S Dillon; W G Nayler
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

8.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.

Authors:  R F Furchgott; J V Zawadzki
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

9.  The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes.

Authors:  A Inoue; M Yanagisawa; S Kimura; Y Kasuya; T Miyauchi; K Goto; T Masaki
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

10.  Endothelin action: Inhibition by a protein kinase C inhibitor and involvement of phosphoinositols.

Authors:  M Sugiura; T Inagami; G M Hare; J A Johns
Journal:  Biochem Biophys Res Commun       Date:  1989-01-16       Impact factor: 3.575

View more
  21 in total

Review 1.  Emerging therapies for heart failure: renal mechanisms and effects.

Authors:  Amir Kazory; Edward A Ross
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

Review 2.  Endothelin A receptor antagonists in congestive heart failure: blocking the beast while leaving the beauty untouched?

Authors:  L E Spieker; G Noll; F T Ruschitzka; T F Lüscher
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

Review 3.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

4.  The effect of changes in adrenal blood flow on adrenal cortical responses to adrenocorticotrophin in conscious calves.

Authors:  C T Jones; A V Edwards; S R Bloom
Journal:  J Physiol       Date:  1990-10       Impact factor: 5.182

Review 5.  The clinical potential of endothelin receptor antagonists in cardiovascular medicine.

Authors:  C J Ferro; D J Webb
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

6.  Differential distribution of endothelin peptides and receptors in human adrenal gland.

Authors:  A P Davenport; S L Hoskins; R E Kuc; C Plumpton
Journal:  Histochem J       Date:  1996-11

7.  Dysregulated aldosterone secretion in persons of African descent with endothelin-1 gene variants.

Authors:  Jia W Tan; Tina Gupta; Worapaka Manosroi; Tham M Yao; Paul N Hopkins; Jonathan S Williams; Gail K Adler; Jose R Romero; Gordon H Williams
Journal:  JCI Insight       Date:  2017-12-07

8.  Endothelin action in rat liver. Receptors, free Ca2+ oscillations, and activation of glycogenolysis.

Authors:  C Serradeil-Le Gal; C Jouneaux; A Sanchez-Bueno; D Raufaste; B Roche; A M Préaux; J P Maffrand; P H Cobbold; J Hanoune; S Lotersztajn
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

9.  Hepatic effects of endothelin. Receptor characterization and endothelin-induced signal transduction in hepatocytes.

Authors:  C R Gandhi; R H Behal; S A Harvey; T A Nouchi; M S Olson
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

Review 10.  Potential of endothelin-1 and vasopressin antagonists for the treatment of congestive heart failure.

Authors:  Navneet S Rehsia; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2010-01       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.